These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11604021)

  • 61. Selection of predictor variables for pneumonia using neural networks and genetic algorithms.
    Heckerling PS; Gerber BS; Tape TG; Wigton RS
    Methods Inf Med; 2005; 44(1):89-97. PubMed ID: 15778799
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Toward an Optimal Approach for Variable Selection in Counter-Propagation Neural Networks: Modeling Protein-Tyrosine Kinase Inhibitory of Flavanoids Using Substituent Electronic Descriptors.
    Hemmateenejad B; Mehdipour A; Deeb O; Sanchooli M; Miri R
    Mol Inform; 2011 Dec; 30(11-12):939-49. PubMed ID: 27468149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. QSAR modeling of the inhibition of glycogen synthase kinase-3.
    Katritzky AR; Pacureanu LM; Dobchev DA; Fara DC; Duchowicz PR; Karelson M
    Bioorg Med Chem; 2006 Jul; 14(14):4987-5002. PubMed ID: 16650999
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of the modelling power approach to variable subset selection for GA-PLS QSAR models.
    Sagrado S; Cronin MT
    Anal Chim Acta; 2008 Feb; 609(2):169-74. PubMed ID: 18261511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predicting activities without computing descriptors: graph machines for QSAR.
    Goulon A; Picot T; Duprat A; Dreyfus G
    SAR QSAR Environ Res; 2007; 18(1-2):141-53. PubMed ID: 17365965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancement of binary QSAR analysis by a GA-based variable selection method.
    Gao H; Lajiness MS; Van Drie J
    J Mol Graph Model; 2002 Jan; 20(4):259-68. PubMed ID: 11858634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. "In silico" design of potential anti-HIV actives using fragment descriptors.
    Varnek A; Solov'ev VP
    Comb Chem High Throughput Screen; 2005 Aug; 8(5):403-16. PubMed ID: 16101580
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Particle swarm algorithm trained neural network for QSAR studies of inhibitors of platelet-derived growth factor receptor phosphorylation.
    Shen Q; Shi WM; Yang XP; Ye BX
    Eur J Pharm Sci; 2006 Aug; 28(5):369-76. PubMed ID: 16713200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. QSAR analysis for some diaryl-substituted pyrazoles as CCR2 inhibitors by GA-stepwise MLR.
    Saghaie L; Shahlaei M; Fassihi A; Madadkar-Sobhani A; Gholivand MB; Pourhossein A
    Chem Biol Drug Des; 2011 Jan; 77(1):75-85. PubMed ID: 21118376
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Robust QSAR models using Bayesian regularized neural networks.
    Burden FR; Winkler DA
    J Med Chem; 1999 Aug; 42(16):3183-7. PubMed ID: 10447964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies.
    Contreras-Romo MC; Martínez-Archundia M; Deeb O; Slusarz MJ; Ramírez-Salinas G; Garduño-Juárez R; Quintanar-Stephano A; Ramírez-Galicia G; Correa-Basurto J
    Chem Biol Drug Des; 2014 Feb; 83(2):207-23. PubMed ID: 24010681
    [TBL] [Abstract][Full Text] [Related]  

  • 72. QSAR studies of bioactivities of 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 receptor ligands using physicochemical descriptors and MLR and ANN-modeling.
    Goodarzi M; Freitas MP; Ghasemi N
    Eur J Med Chem; 2010 Sep; 45(9):3911-5. PubMed ID: 20547432
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unsupervised forward selection: a method for eliminating redundant variables.
    Whitley DC; Ford MG; Livingstone DJ
    J Chem Inf Comput Sci; 2000; 40(5):1160-8. PubMed ID: 11045809
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Locally linear embedding for dimensionality reduction in QSAR.
    L'Heureux PJ; Carreau J; Bengio Y; Delalleau O; Yue SY
    J Comput Aided Mol Des; 2004; 18(7-9):475-82. PubMed ID: 15729847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 76. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
    Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
    J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
    Tropsha A; Zheng W
    Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative molecular field analysis (coMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods.
    Lee KW; Briggs JM
    J Comput Aided Mol Des; 2001 Jan; 15(1):41-55. PubMed ID: 11217918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Silico Study of In Vitro GPCR Assays by QSAR Modeling.
    Mansouri K; Judson RS
    Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Application of topological descriptors in QSAR and drug design: history and new trends.
    Gozalbes R; Doucet JP; Derouin F
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.